Hair growth products in India is emerging as a high-growth consumer wellness category, with the alopecia-driven segment expected to more than double to $546 million by 2028 from $267 million in 2023 says the 'India Hair Growth Market Report' by Redseer Strategy Consultants, published in August 2026. Supplements, omnichannel distribution and rising FMCG interest is reshaping a market long dominated by pharmaceutical interventions.

The market, projected to grow at 14-15% CAGR, is at an inflection point where consumer demand, product innovation and consumer goods capital are converging, creating what the consultancy describes as a significant white-space opportunity for scale brands.

A major driver of this shift is supplements, now the fastest-growing segment in the category, expected to grow at 18% CAGR through 2028, outpacing traditional topical solutions that have historically defined the market.

The transition reflects a broader shift in consumer behaviour—from prescription-led treatments towards everyday, non-invasive and evidence-backed wellness solutions. Increasingly, consumers are opting for supplements and medicated products that fit into routine preventive care, rather than relying solely on doctor-led clinical interventions.

The timing appears opportune. Redseer estimates 82 million urban Indians currently face hair loss, yet only about 5 million use over-the-counter (OTC) or non-prescriptive solutions, pointing to a large underpenetrated market waiting to be unlocked.

Where is the mass-market opportunity emerging?

What makes the opportunity compelling for consumer brands is the affordability gap.

More than 90% of consumers spend less than ₹1,000 a month on hair-loss solutions, while several organised offerings remain priced above this threshold, leaving room for a value-led disruption play.

That price gap, coupled with a fragmented competitive landscape, is attracting growing attention from FMCG and beauty and personal care (BPC) players seeking new growth adjacencies.

The report notes topical solutions still account for 62% of the market, but no dominant leader has emerged across sub-segments, leaving the category open for challengers. Supplements and medicated products, in particular, remain highly fragmented, creating room for scaled entrants to consolidate demand.

“The category has moved beyond proving efficacy. The bigger opportunity now lies in solving affordability and access at scale,” the report says.

How is omnichannel reshaping growth in the category?

Equally significant is the evolution of distribution, the report explains.

India’s hair growth market has moved through three distinct eras over two decades—from a pharma-led model to pharma-plus-FMCG participation, and now into an omnichannel phase where D2C brands, online marketplaces, quick commerce and offline retail are jointly driving discovery and repeat purchase.

That evolution is fundamentally changing the competitive playbook.

Rather than relying solely on prescription credibility, newer brands are increasingly combining digital discovery with offline trust-building—an approach Redseer sees as central to future category leadership.

The shift also aligns with rising investor conviction in the space.

Recent investments and acquisitions—including HUL’s bets on OZiva and Wellbeing Nutrition, Marico’s Plix acquisition, and Tata Consumer Products’ buyout of Organic India—underscore growing corporate interest in hair wellness and nutraceutical adjacencies, says the report. Globally too, large consumer goods companies have been expanding into the segment through acquisitions.

Why is wellness-led consumption taking centre stage?

The report suggests that India is mirroring a broader global move where hair growth is transitioning from a treatment category into a wellness-led consumption story.

Globally, supplements are scaling significantly faster than legacy topicals, and India, rather than following the trend late, may be emerging at its leading edge.

For brands, the next opportunity may lie not in clinical innovation alone but in building accessible, trusted and mass-market wellness products around hair health.

Redseer argues the eventual category winner will likely be the player that cracks three things simultaneously—solving for the ₹500-1,000 monthly affordability band, committing to focused consumer cohorts, and investing in long-term category creation.

That could mark a shift in how India views hair-loss solutions altogether—from a pharmacy purchase to a mainstream consumer product.

And for FMCG companies looking for the next wellness growth engine, the category may be moving from niche to strategic faster than expected.